Covidien, a global provider of healthcare products, announce an extended offering of its market-leading Kendall line of wound care bandages, dressings and gauze, sold under the brand names of Curity™, Kerlix™, Telfa™, Dermacea™ and others, are now available through Cardinal Health.
Cardinal Health’s sales teams will work closely with their customers to ensure a smooth, timely and cost effective transition from Cardinal Health’s line of private-label wound care products to Covidien’s line of wound care products.
“Our enhanced partnership with Cardinal Health unlocks the synergy that exists between our organizations and provides a one-stop buying experience for wound care products. The real winner is the customer, who will receive an expanded portfolio of the highest quality, best performing products, while being serviced by two of the best sales and support organizations in the business,” said Jim Clemmer, president of medical supplies at Covidien.
Covidien’s products will be offered as part of Cardinal Health’s Best Value® program, which provides customers with a select offering of high quality products in specific categories at market competitive prices.
Cardinal Health customers who would like more information about Kendall wound care products should contact Covidien at (800) 962-9888.
Source: Covidien
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.